Anyang Jiuzhou Pharmaceuticals

Shanghai Jindi Jiuzhou (Anyang) Pharmaceutical Co., Ltd., formerly known as Anyang Jiuzhou Pharmaceutical Co., Ltd., is a prominent pharmaceutical manufacturer based in Henan Province, China, and a subsidiary of Shuzhong Group. Established in 1998 and restructured in 2014, the company specializes in the production of active pharmaceutical ingredients (APIs) and small-volume parenteral injections. Its extensive product portfolio includes over 90 varieties of drugs, such as diclofenac sodium, erythromycin thiocyanate, tylosin tartrate, and various vitamin injections, which are manufactured under strict GMP standards. The company's products are widely distributed domestically and exported to international markets across Southeast Asia, Africa, South America, and Europe. Shanghai Jindi Jiuzhou continues to expand its capabilities in chemical synthesis and bio-fermentation while developing new generic formulations like tadalafil and hydroxocobalamin.